Physician profile
Andrew D Stone
NPI 1497795561
$516.02
in general payments reported to CMS, 2019-2025
8 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $164 · 2024: $142 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $160.83 | 2025 | Phasix Mesh |
| Gilead Sciences, INC. | $125.00 | 2024 | Livdelzi |
| Medtronic, INC. | $99.24 | 2023 | Barrx |
| Lucid Diagnostics INC. | $35.79 | 2024-2025 | |
| Madrigal Pharmaceuticals | $30.74 | 2025 | Rezdiffra |
| Capsovision, INC. | $29.47 | 2023 | Capsocam Plus |
| Genzyme Corporation | $20.47 | 2023 | |
| Abbvie INC. | $14.48 | 2023 | Rinvoq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.